- The diagnostic lab chain sees weak response from investors on the second day of the IPO bidding as well.
Vijaya Diagnostic IPO was subscribed 0.47 times on September 2.- Analysts recommend subscribing to the stock for the long term relying on the company’s strong presence in south India.
Overall, Vijaya Diagnostic’s IPO was subscribed 0.47 times. The IPO received bids for 1.81 crore equity shares as against the issue size of 2.50 crore equity shares.
The grey market premium for the IPO was also not very exciting as it indicates ₹15-₹20 premium.
The firm has ₹250 crore cash on its books, Sunil Chandra Kondapally, executive director at Vijaya Diagnostic, told Business Insider.
The company offers a “one-stop solution” for pathology and radiology testing services through its 80 diagnostic centres and 11 reference laboratories i.e. labs that perform routine and speciality tests in high volume, across 13 cities and towns in the states of Telangana and Andhra Pradesh. The company claims it has a 7% market share in the two states with an estimated market size of ₹5,100 crore.
SEE ALSO: